Quantum Mechanical Calculations and Molecular Docking Simulation Studies of N-(5-chloro-2-oxobenzyl)-2-hydroxy-5-methylanilinium Compound
Abstract
Keywords
Quantum mechanical calculations, Molecular docking, Alzheimer’s disease, AChE, MOA-B.
References
- [1] H. Schiff, “Unterscuhgen über Slicinderivative”, Justus Liebigs Annalen der Chemier vol. 150, no. 2, pp. 193-200, 1869.
- [2] A. Hameed, M. Al-Rashida, S. M. Abid Ali, and K. M. Khan, “Schiff bases in medicinal chemistry: A patent review (2010-2015)”, Expert Opinion on Therapeutic Patents, vol. 27, no. 1, pp. 63-79, 2017. https://doi.org/10.1080/13543776.2017.1252752.
- [3] H. M. Alkahtani, A. A. Almehizia, M. A. Al-Omar, A. J. Obaidullah, A. A. Zen, A. S. Hassan, and W. M. Aboulthana, “In vitro evaluation and bioinformatics analysis of Schiff bases bearing pyrazole scaffold as bioactive agents: Antioxidant, anti-diabetic, anti-Alzheimer, and anti-arthritic”, Molecules, vol. 28, no. 20, 7125, 2023. https://doi.org/10.3390/molecules28207125.
- [4] B. Pinchaipat, R. Chotima, M. Promkatkaew, S. Kitjaruwankul, K. Chainok, and T. Khudkham, “Experimental and theoretical studies on DNA binding and anticancer activity of nickel(II) and zinc(II) complexes with N-(8-quinolyl) salicylaldimine Schiff base ligands”, Chemistry, vol. 6, no. 4, pp. 618-639, 2024. https://doi.org/10.3390/chemistry6040037.
- [5] J. Branković, M. G. Krokidis, I. Dousi, K. Papadopoulos, Z. D. Petrović, and V. P. Petrović, “Antioxidant and cytotoxic activities of selected salicylidene imines: Experimental and computational study”, Molecular Diversity, vol. 26, no. 6, 3115-3128, 2022. https://doi.org/10.1007/s11030-021-10370-9.
- [6] D. Sarker, K. N. Ahmed, M. S. Rahman, and M. A. Kawsar, “Copper (II) complex of salicylaldehyde semicarbazone: Synthesis, characterization and antibacterial activity”. Asian Journal of Chemical Sciences, vol 6, no. 4, pp. 1-8, 2019. https://doi.org/10.9734/ajocs/2019/v6i430173.
- [7] U. Saray and U. Çavdar, "Investigating the role of artificial intelligence in the diagnosis and treatment of Alzheimer’s disease," in VIII. International Scientific and Vocational Studies Congress (BILMES 2023), Turkey, Dec. 22-24, 2023, pp. 132-137. ISBN: 978-605-71214-9-3.
- [8] I. Vecchio, L. Sorrentino, A. Paoletti, R. Marra, and M. Arbitrio, “The state of the art on acetylcholinesterase inhibitors in the treatment of Alzheimer’s disease”, Journal of Central Nervous System Disease, pp. 1-13, 2021. https://doi.org/10.1177/11795735211029113.
- [9] C. P. Ferri, M. Prince, C. Brayne, H. Brodaty, L. Fratiglioni, M. Ganguli, K. Hall, K. Hasegawa, H. Hendrie, Y. Huang, A. Jorm, C. Mathers, P. R. Menezes, E. Rimmer, and M. Scazufca, “Global prevalence of dementia: A Delphi consensus study”. The Lancet, vol. 366, no. 9503, pp. 2112-2117, 2005. https://doi.org/10.1016/S0140-6736(05)67889-0.
- [10] E. Bomasang-Layno, and R. Bronsther, “Diagnosis and treatment of Alzheimer’s disease: An update”, Dela Journal of Public Health, vol. 7, no. 4, pp. 74-85, 2021. https://doi.org/10.32481/djph.2021.09.009.